Since KIR3DL1 positivity was 94.7% in HCV-associated cirrhosis in our cohort, it was difficult to conclusively ascertain HLA-Bw4 or KIR3DL1 + HLA-Bw4 as risk factors for HCC development. Here, KIR3DL1 is linked to hepatocellular carcinoma.